ConductScience.org, home

Paper33859638

Cancer Vaccines, Adjuvants, and Delivery Systems.

Paston SJ and 3 others. Front Immunol, 2021. Cited by 156 papers, by iCite.

Cite this record

ConductScience Library. Cancer Vaccines, Adjuvants, and Delivery Systems. Papers, record 33859638. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/33859638

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Cancer Vaccines, Adjuvants, and Delivery Systems.
PubMed
Journal
Front Immunol
PubMed
Year
2021
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't, Review
PubMed
Citations, by iCite
156
iCite
Relative citation ratio, by iCite
8.71
iCite
Revised in PubMed
2026-01-27
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Paston SJSamantha J
2Brentville VAVictoria A
3Symonds PPeter
4Durrant LGLindy G

Source PubMed

Download CSV of authors

Topics15

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Adjuvants, ImmunologicMajor topic
Antigens, NeoplasmMajor topic
Cancer VaccinesMajor topic
Drug Delivery SystemsMajor topic
Gene Transfer TechniquesMajor topic
NeoplasmsMajor topic
Animals
Drug Carriers
Drug Compounding
Humans
Tumor Escape
Tumor Microenvironment
Vaccines, DNA
Vaccines, Synthetic
mRNA Vaccines

Source PubMed

Download CSV of topics

References278

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
117616674Breast cancer antiestrogen resistance-3 expression regulates breast cancer cell migration through promotion of p130Cas membrane localization and membrane ruffling.Cancer Res2007https://conductscience.org/library/papers/17616674PubMed
229443960TGFβ attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells.Nature2018https://conductscience.org/library/papers/29443960PubMed
314613989Recursive partitioning as an approach to selection of immune markers for tumor diagnosis.Clin Cancer Res2003https://conductscience.org/library/papers/14613989PubMed
41545867Genetic immunization is a simple method for eliciting an immune response.Nature1992https://conductscience.org/library/papers/1545867PubMed
516914222Cationic lipids, lipoplexes and intracellular delivery of genes.J Control Release2006https://conductscience.org/library/papers/16914222PubMed
625959818Direct Activation of STING in the Tumor Microenvironment Leads to Potent and Systemic Tumor Regression and Immunity.Cell Rep2015https://conductscience.org/library/papers/25959818PubMed
723348506Highly recurrent TERT promoter mutations in human melanoma.Science2013https://conductscience.org/library/papers/23348506PubMed
829472691A reappraisal of CTLA-4 checkpoint blockade in cancer immunotherapy.Cell Res2018https://conductscience.org/library/papers/29472691PubMed
929321773The Potential of Donor T-Cell Repertoires in Neoantigen-Targeted Cancer Immunotherapy.Front Immunol2017https://conductscience.org/library/papers/29321773PubMed
1032728218An RNA vaccine drives immunity in checkpoint-inhibitor-treated melanoma.Nature2020https://conductscience.org/library/papers/32728218PubMed
1110961895Prognostic significance of survivin expression in diffuse large B-cell lymphomas.Blood2000https://conductscience.org/library/papers/10961895PubMed
1226214521Therapeutic cancer vaccines.J Clin Invest2015https://conductscience.org/library/papers/26214521PubMed
1310727458Multiple genetic alterations cause frequent and heterogeneous human histocompatibility leukocyte antigen class I loss in cervical cancer.J Exp Med2000https://conductscience.org/library/papers/10727458PubMed
1425428507Checkpoint blockade cancer immunotherapy targets tumour-specific mutant antigens.Nature2014https://conductscience.org/library/papers/25428507PubMed
1521665146Receptor tyrosine kinases and TLR/IL1Rs unexpectedly activate myeloid cell PI3kγ, a single convergent point promoting tumor inflammation and progression.Cancer Cell2011https://conductscience.org/library/papers/21665146PubMed
1622808118Antibody-antigen-adjuvant conjugates enable co-delivery of antigen and adjuvant to dendritic cells in cis but only have partial targeting specificity.PLoS One2012https://conductscience.org/library/papers/22808118PubMed
1721567378Identification and functional characterization of T cells reactive to citrullinated vimentin in HLA-DRB1*0401-positive humanized mice and rheumatoid arthritis patients.Arthritis Rheum2011https://conductscience.org/library/papers/21567378PubMed
1826291480A7RC peptide modified paclitaxel liposomes dually target breast cancer.Biomater Sci2015https://conductscience.org/library/papers/26291480PubMed
198183550Hyperphosphorylation of a novel 80 kDa protein-tyrosine kinase similar to Ltk in a human Ki-1 lymphoma cell line, AMS3.Oncogene1994https://conductscience.org/library/papers/8183550PubMed
2024048523MHC class I-associated phosphopeptides are the targets of memory-like immunity in leukemia.Sci Transl Med2013https://conductscience.org/library/papers/24048523PubMed

See all 278 referencesDownload CSV of references

Cited by121

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 156 citations.

PMIDTitleJournalYearIn PapersSource
42898410Platform-based manufacturing of tumor-infiltrating lymphocytes derived from different solid tumor types.Front Immunol2026https://conductscience.org/library/papers/42898410PubMed
42670587Superantigens in Cancer Immunotherapy: Mechanisms, Engineering Strategies, and Therapeutic Potential.FASEB J2026https://conductscience.org/library/papers/42670587PubMed
42646710The State-of-the Art of Personalized Vaccines for Non-Communicable Diseases: A Narrative Review.Vaccines (Basel)2026https://conductscience.org/library/papers/42646710PubMed
42506595Immunogenicity of an Oil-in-Water Emulsion Containing Hafnia Alvei-Derived Lipopolysaccharide, with TLR4 and Dectin-2 Agonist Activity In Vitro.Vaccines (Basel)2026https://conductscience.org/library/papers/42506595PubMed
42494420Erythrocyte-inspired biomaterials for cancer immunotherapy: Integration within the cancer-immunity cycle.Mater Today Bio2026https://conductscience.org/library/papers/42494420PubMed
42481451Personalized cancer vaccines: bridging immune-oncology and precision medicine for advanced therapeutics.Signal Transduct Target Ther2026https://conductscience.org/library/papers/42481451PubMed
42328446RMAD1, a Novel Cell-Penetrating Peptide Derived from ADARB2: Preclinical Insights into Antigen Uptake and T Cell Activation.Int J Biol Sci2026https://conductscience.org/library/papers/42328446PubMed
42327740Identification of tumor-associated antigens with multi-cancer therapeutic potential.Front Immunol2026https://conductscience.org/library/papers/42327740PubMed
42257193Synthetic Polymers for Drug, Gene, and Vaccine Delivery.Polym Sci Technol2025https://conductscience.org/library/papers/42257193PubMed
41946315Nanoparticle-mediated dual delivery of MHC class I and II antigens enhances T cell immunity and anti-tumor potency.Biomaterials2026https://conductscience.org/library/papers/41946315PubMed
41810102Tumor Vaccines in Hepatocellular Carcinoma: Advances, Challenges, and the Path Toward Precision Immunotherapy.J Clin Transl Hepatol2026https://conductscience.org/library/papers/41810102PubMed
41669116Leveraging T cells for cancer immunotherapy.Immun Inflamm2025https://conductscience.org/library/papers/41669116PubMed
41621014CTLA-4: a promising immunosuppressive immune checkpoint in prostate cancer therapy.Clin Transl Oncol2026https://conductscience.org/library/papers/41621014PubMed
41614820Cancer Vaccines: Molecular Mechanisms, Clinical Progress, and Combination Immunotherapies with a Focus on Hepatocellular Carcinoma.Curr Issues Mol Biol2025https://conductscience.org/library/papers/41614820PubMed
41309533Targeting KRAS mutations: orchestrating cancer evolution and therapeutic challenges.Signal Transduct Target Ther2025https://conductscience.org/library/papers/41309533PubMed
41286148Targeting SOX9: designing a novel vaccine against triple-negative breast cancer.Sci Rep2025https://conductscience.org/library/papers/41286148PubMed
41146660Biomimetic nanovesicle vaccines derived from dendritic cells sensitized with whole tumor antigens for melanoma immunotherapy.Mater Today Bio2025https://conductscience.org/library/papers/41146660PubMed
41132679Insights into tumor vaccines for elderly individuals in the context of immunosenescence.Front Immunol2025https://conductscience.org/library/papers/41132679PubMed
41072409Super-adjuvant nanoparticles for platform cancer vaccination.Cell Rep Med2025https://conductscience.org/library/papers/41072409PubMed
41063530Research hotspots and trends in tumor vaccine adjuvants: A bibliometric analysis from 2010 to 2024.Hum Vaccin Immunother2025https://conductscience.org/library/papers/41063530PubMed

See all 121 cited byDownload CSV of cited by

Genes60

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
ABL125PubTator's text mininghttps://conductscience.org/library/genes/25NCBI Gene
ALK238PubTator's text mininghttps://conductscience.org/library/genes/238NCBI Gene
B2M567PubTator's text mininghttps://conductscience.org/library/genes/567NCBI Gene
BAGE574PubTator's text mininghttps://conductscience.org/library/genes/574NCBI Gene
BCAR38412PubTator's text mininghttps://conductscience.org/library/genes/8412NCBI Gene
CA2760PubTator's text mininghttps://conductscience.org/library/genes/760NCBI Gene
CD14929PubTator's text mininghttps://conductscience.org/library/genes/929NCBI Gene
CD19930PubTator's text mininghttps://conductscience.org/library/genes/930NCBI Gene
CD27429126PubTator's text mininghttps://conductscience.org/library/genes/29126NCBI Gene
CD4920PubTator's text mininghttps://conductscience.org/library/genes/920NCBI Gene
CD58965PubTator's text mininghttps://conductscience.org/library/genes/965NCBI Gene
CD80941PubTator's text mininghttps://conductscience.org/library/genes/941NCBI Gene
CD8A925PubTator's text mininghttps://conductscience.org/library/genes/925NCBI Gene
CEACAM31084PubTator's text mininghttps://conductscience.org/library/genes/1084NCBI Gene
CIITA4261PubTator's text mininghttps://conductscience.org/library/genes/4261NCBI Gene
CNTN26900PubTator's text mininghttps://conductscience.org/library/genes/6900NCBI Gene
COL9A21298PubTator's text mininghttps://conductscience.org/library/genes/1298NCBI Gene
CSF21437PubTator's text mininghttps://conductscience.org/library/genes/1437NCBI Gene
CTAG1A246100PubTator's text mininghttps://conductscience.org/library/genes/246100NCBI Gene
CTLA41493PubTator's text mininghttps://conductscience.org/library/genes/1493NCBI Gene

See all 60 genesDownload CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/33859638

GET https://conductscience.org/api/papers/v1/33859638/references?page=2